For contact lens wearers with conjunctivitis, is polymyxin B/trimethoprim (Polytrim) the first‑line treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Polytrim is NOT first-line for contact lens wearers with conjunctivitis

Contact lens wearers with conjunctivitis require coverage for Pseudomonas aeruginosa, which Polytrim (polymyxin B/trimethoprim) does not adequately provide. This is a critical distinction that can prevent vision-threatening bacterial keratitis.

Why Contact Lens Wearers Are Different

Contact lens wear is a major risk factor for bacterial keratitis, with Pseudomonas aeruginosa being the most common gram-negative pathogen in this population 1. The risk is particularly elevated with:

  • Overnight wear (5-fold increased risk of corneal infection)
  • Poor lens hygiene
  • Water exposure while wearing lenses
  • Contaminated lens cases 1

The Problem with Polytrim in Contact Lens Wearers

While Polytrim is effective for general bacterial conjunctivitis in non-contact lens wearers 2, 3, it has inadequate Pseudomonas coverage. The polymyxin B component provides some gram-negative activity, but this is insufficient for the aggressive Pseudomonas infections that contact lens wearers are prone to develop.

Evidence on Polytrim's General Efficacy

  • In pediatric conjunctivitis (non-contact lens wearers), Polytrim showed 96% clinical cure rates 2
  • However, these studies specifically excluded contact lens-related infections
  • Polytrim works well for common pathogens like Haemophilus influenzae and Streptococcus pneumoniae 2, 3

What You Should Use Instead

Fluoroquinolones (moxifloxacin, ciprofloxacin, or levofloxacin) are the appropriate first-line choice for contact lens wearers with conjunctivitis because they provide robust Pseudomonas coverage 4, 5.

Supporting Evidence:

  • Moxifloxacin demonstrated faster bacterial killing of common pathogens and achieved 81% complete resolution by 48 hours versus 44% with Polytrim 4
  • Fluoroquinolones have broad-spectrum activity including excellent Pseudomonas coverage 5
  • The bacterial keratitis guidelines emphasize fortified antibiotics (ceftazidime for Pseudomonas, vancomycin for gram-positives) for serious contact lens-related infections 1

Critical Clinical Pitfall

Never assume simple conjunctivitis in a contact lens wearer. These patients are at high risk for bacterial keratitis, which can rapidly progress to vision loss. Any contact lens wearer with:

  • Eye redness
  • Pain (not just irritation)
  • Photophobia
  • Decreased vision
  • Discharge

Should have their contact lenses immediately removed and be evaluated for corneal involvement 1. If there's any question of keratitis versus simple conjunctivitis, treat as keratitis with fluoroquinolones or refer urgently to ophthalmology.

Bottom Line Algorithm

For contact lens wearers with conjunctivitis:

  1. Remove contact lenses immediately
  2. Prescribe a fluoroquinolone (moxifloxacin 0.5% TID or ciprofloxacin 0.3% QID)
  3. Do NOT restart contact lens wear until completely resolved and cleared by examination
  4. If any corneal involvement suspected → urgent ophthalmology referral

Reserve Polytrim for non-contact lens wearers with straightforward bacterial conjunctivitis where cost is a significant concern 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.